RESEARCHERS at Oxford
University in the UK have published
a study which show a substantial
reduction in death rates from
cancer in patients who took a small
daily dose of aspirin.
The research looked at 25,000
patients across the UK over a foureight
year period, and found that
those who took aspirin had a 25%
lower risk of death from cancer
during the trial period, and a 10%
reduction in death from any cause.
The benefits accrued even with a
dose as low as 75mg per day, with
lead researcher Prof Peter Rothwell
suggesting it would be helpful for
daily aspirin to commence around
the age of 45-50 years.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Dec 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Dec 10
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.